Reply to D'Alessandro-Gabazza et al.: Risks of Treating Idiopathic Pulmonary Fibrosis with a TAM Receptor Kinase Inhibitor.
作者信息
Espindola Milena S, Habiel David M, Hogaboam Cory M
机构信息
1 Cedars-Sinai Medical Center Los Angeles, California.
出版信息
Am J Respir Crit Care Med. 2018 Oct 1;198(7):971-973. doi: 10.1164/rccm.201805-0972LE.
Abstract
摘要
相似文献
1
Reply to D'Alessandro-Gabazza et al.: Risks of Treating Idiopathic Pulmonary Fibrosis with a TAM Receptor Kinase Inhibitor.对亚历山德罗 - 加巴扎等人的回复：使用酪氨酸激酶受体抑制剂治疗特发性肺纤维化的风险。
Am J Respir Crit Care Med. 2018 Oct 1;198(7):971-973. doi: 10.1164/rccm.201805-0972LE.
2
Risks of Treating Idiopathic Pulmonary Fibrosis with a TAM Receptor Kinase Inhibitor.用酪氨酸激酶受体抑制剂治疗特发性肺纤维化的风险
Am J Respir Crit Care Med. 2018 Oct 1;198(7):970-971. doi: 10.1164/rccm.201805-0871LE.
3
Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.靶向 TAM 受体可改善特发性肺纤维化中的纤维化机制。
Am J Respir Crit Care Med. 2018 Jun 1;197(11):1443-1456. doi: 10.1164/rccm.201707-1519OC.
4
Reply: Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.回复：尼达尼布对特发性肺纤维化患者的疗效。
Am J Respir Crit Care Med. 2017 May 1;195(9):1275. doi: 10.1164/rccm.201610-2155LE.
5
Reply: Weight-Loss Effect on FVC in Nintedanib Idiopathic Pulmonary Fibrosis Trials?回复：在尼达尼布治疗特发性肺纤维化试验中体重减轻对用力肺活量的影响？
Am J Respir Crit Care Med. 2015 Oct 15;192(8):1020-1. doi: 10.1164/rccm.201507-1354LE.
6
Reply to Rajchgot et al.: Combination Nintedanib and Pirfenidone for Treatment of Idiopathic Pulmonary Fibrosis.对拉伊乔特等人的回复：尼达尼布与吡非尼酮联合治疗特发性肺纤维化
Am J Respir Crit Care Med. 2018 Oct 15;198(8):1105-1106. doi: 10.1164/rccm.201806-1116LE.
7
Reply to Nett : Collecting Occupational Exposure Data Would Strengthen Idiopathic Pulmonary Fibrosis Registries.回复内特：收集职业暴露数据将加强特发性肺纤维化登记系统。
Am J Respir Crit Care Med. 2020 Feb 15;201(4):496-497. doi: 10.1164/rccm.201910-2010LE.
8
Reply to Puxeddu : CD71 Alveolar Macrophages in Idiopathic Pulmonary Fibrosis: A Look beyond the Borders of the Disease.对普克塞杜的回复：特发性肺纤维化中的CD71肺泡巨噬细胞：超越疾病边界的审视
Am J Respir Crit Care Med. 2019 Dec 1;200(11):1446-1447. doi: 10.1164/rccm.201907-1347LE.
9
Is nintedanib effective for idiopathic pulmonary fibrosis?尼达尼布对特发性肺纤维化有效吗？
Medwave. 2017 Apr 10;17(Suppl2):e6918. doi: 10.5867/medwave.2017.6918.
10
Treatments for idiopathic pulmonary fibrosis.特发性肺纤维化的治疗方法。
N Engl J Med. 2014 Aug 21;371(8):783. doi: 10.1056/NEJMc1407776.
引用本文的文献
1
IL-18/IL-18R1 promotes circulating fibrocyte differentiation in the aging population.IL-18/IL-18R1 促进老年人群循环成纤维细胞的分化。
Inflamm Res. 2020 May;69(5):497-507. doi: 10.1007/s00011-020-01330-4. Epub 2020 Mar 19.
本文引用的文献
1
Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.靶向 TAM 受体可改善特发性肺纤维化中的纤维化机制。
Am J Respir Crit Care Med. 2018 Jun 1;197(11):1443-1456. doi: 10.1164/rccm.201707-1519OC.
2
Modeling Idiopathic Pulmonary Fibrosis in Humanized Severe Combined Immunodeficient Mice.在人源化严重联合免疫缺陷小鼠中建立特发性肺纤维化模型。
Am J Pathol. 2018 Apr;188(4):891-903. doi: 10.1016/j.ajpath.2017.12.020. Epub 2018 Feb 17.
3
Lung Gene Expression Analysis (LGEA): an integrative web portal for comprehensive gene expression data analysis in lung development.肺基因表达分析（LGEA）：一个用于肺发育中综合基因表达数据分析的集成网络门户。
Thorax. 2017 May;72(5):481-484. doi: 10.1136/thoraxjnl-2016-209598. Epub 2017 Jan 9.
4
Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis.单细胞 RNA 测序鉴定特发性肺纤维化中上皮细胞的多种作用。
JCI Insight. 2016 Dec 8;1(20):e90558. doi: 10.1172/jci.insight.90558.
5
Protein S is protective in pulmonary fibrosis.蛋白质 S 在肺纤维化中具有保护作用。
J Thromb Haemost. 2016 Aug;14(8):1588-99. doi: 10.1111/jth.13362. Epub 2016 Jun 22.
6
'LungGENS': a web-based tool for mapping single-cell gene expression in the developing lung.“LungGENS”：一种用于绘制发育中肺部单细胞基因表达图谱的基于网络的工具。
Thorax. 2015 Nov;70(11):1092-4. doi: 10.1136/thoraxjnl-2015-207035. Epub 2015 Jun 30.
7
Biology of the TAM receptors.TAM 受体的生物学特性
Cold Spring Harb Perspect Biol. 2013 Nov 1;5(11):a009076. doi: 10.1101/cshperspect.a009076.
8
Serum analysis of coagulation factors in IPF and NSIP.特发性肺纤维化和非特异性间质性肺炎患者的凝血因子血清分析。
Inflammation. 2014 Feb;37(1):10-6. doi: 10.1007/s10753-013-9706-z.
9
The gene coding for the beta-chain of C4b-binding protein (C4BPB) has become a pseudogene in the mouse.编码C4b结合蛋白β链（C4BPB）的基因在小鼠中已成为假基因。
Genomics. 1994 Jun;21(3):501-9. doi: 10.1006/geno.1994.1308.
10
High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein.人血浆中维生素K依赖蛋白S与补体成分C4b结合蛋白之间的高分子量复合物。
Proc Natl Acad Sci U S A. 1981 Apr;78(4):2512-6. doi: 10.1073/pnas.78.4.2512.
Zotero 插件